Study: NCT06430801

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV Tulisokibart
Description: Humanized monoclonal antibody that binds human tumor necrosis factor-like cytokine 1A (TL1A), administered intravenously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV Tulisokibart
Description: Humanized monoclonal antibody that binds human tumor necrosis factor-like cytokine 1A (TL1A), administered intravenously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV Tulisokibart
Description: Humanized monoclonal antibody that binds human tumor necrosis factor-like cytokine 1A (TL1A), administered intravenously

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: IV Tulisokibart
Description: Humanized monoclonal antibody that binds human tumor necrosis factor-like cytokine 1A (TL1A), administered intravenously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV Tulisokibart
Description: Humanized monoclonal antibody that binds human tumor necrosis factor-like cytokine 1A (TL1A), administered intravenously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV Tulisokibart
Description: Humanized monoclonal antibody that binds human tumor necrosis factor-like cytokine 1A (TL1A), administered intravenously

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: IV Tulisokibart
Description: Humanized monoclonal antibody that binds human tumor necrosis factor-like cytokine 1A (TL1A), administered intravenously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SC Tulisokibart
Description: Humanized monoclonal antibody that binds human TL1A, administered subcutaneously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SC Tulisokibart
Description: Humanized monoclonal antibody that binds human TL1A, administered subcutaneously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SC Tulisokibart
Description: Humanized monoclonal antibody that binds human TL1A, administered subcutaneously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SC Tulisokibart
Description: Humanized monoclonal antibody that binds human TL1A, administered subcutaneously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SC Tulisokibart
Description: Humanized monoclonal antibody that binds human TL1A, administered subcutaneously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SC Tulisokibart
Description: Humanized monoclonal antibody that binds human TL1A, administered subcutaneously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SC Tulisokibart
Description: Humanized monoclonal antibody that binds human TL1A, administered subcutaneously

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: IV Placebo
Description: Placebo matching IV tulisokibart

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: IV Placebo
Description: Placebo matching IV tulisokibart

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SC Placebo
Description: Placebo matching SC tulisokibart

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SC Placebo
Description: Placebo matching SC tulisokibart

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SC Placebo
Description: Placebo matching SC tulisokibart

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: SC Placebo
Description: Placebo matching SC tulisokibart

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SC Placebo
Description: Placebo matching SC tulisokibart

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: SC Placebo
Description: Placebo matching SC tulisokibart